Medicalgorithmics Stock

Medicalgorithmics Gross Profit

Gross Profit of Medicalgorithmics (MDG.WA) as of Mar 15, 2026.

Gross Profit

0PLN

Last updated: Mar 15, 2026

Gross Profit of Medicalgorithmics is 2026 0 PLN. Gross Profit of Medicalgorithmics was 2025 0 PLN. It decreases by % lower compared to the previous year.

The Medicalgorithmics Gross Profit history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

GROSS MARGIN (%)
Date
GROSS MARGIN (%)
Jan 1, 2011
5,172 base
Jan 1, 2012
6,364 base
Jan 1, 2013
6,306 base
Jan 1, 2014
4,633 base
Jan 1, 2015
4,234 base
Jan 1, 2016
1,757 base
Jan 1, 2017
2,296 base
Jan 1, 2018
1,680 base
Jan 1, 2019
120 base
Jan 1, 2020
-3,018 base
Jan 1, 2021
7,949 base
Jan 1, 2022
8,030 base
Jan 1, 2023
8,322 base
Jan 1, 2024
8,486 base
Invalid Date
6,599 base
YEARGROSS MARGIN (%)
2028 est 20,84
2027 est 26,50
2026 est 35,33
2025 est 65,99
2024 84,86
2023 83,22
2022 80,30
2021 79,49
2020 -30,18
2019 1,20
2018 16,80
2017 22,96
2016 17,57
2015 42,34
2014 46,33
2013 63,06
2012 63,64
2011 51,72
API Docs Get API Key

Medicalgorithmics Revenue

Medicalgorithmics Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2011
5.8 M PLN
3.1 M PLN
3 M PLN
Jan 1, 2012
11 M PLN
7.1 M PLN
7.4 M PLN
Jan 1, 2013
15.7 M PLN
10 M PLN
10.9 M PLN
Jan 1, 2014
29.71 M PLN
13.89 M PLN
14.53 M PLN
Jan 1, 2015
49.33 M PLN
21.13 M PLN
13.93 M PLN
Jan 1, 2016
127.92 M PLN
18.87 M PLN
40.11 M PLN
Jan 1, 2017
203.35 M PLN
41.82 M PLN
25.54 M PLN
Jan 1, 2018
199.4 M PLN
25.4 M PLN
14.42 M PLN
Jan 1, 2019
173.87 M PLN
55,000 PLN
4.28 M PLN
Jan 1, 2020
111.73 M PLN
-38.46 M PLN
-12.92 M PLN
Jan 1, 2021
48.35 M PLN
12.13 M PLN
-180.64 M PLN
Jan 1, 2022
62.72 M PLN
16.02 M PLN
-11.86 M PLN
Jan 1, 2023
43.1 M PLN
552,000 PLN
-578,000 PLN
Jan 1, 2024
24 M PLN
-13.86 M PLN
-16.08 M PLN
Invalid Date
30.87 M PLN
-10.22 M PLN
-10.9 M PLN

Medicalgorithmics Margins

Medicalgorithmics stock margins

The Medicalgorithmics margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Medicalgorithmics. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Medicalgorithmics.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2011
51.72 %
53.45 %
51.72 %
Jan 1, 2012
63.64 %
64.55 %
67.27 %
Jan 1, 2013
63.06 %
63.69 %
69.43 %
Jan 1, 2014
46.33 %
46.75 %
48.89 %
Jan 1, 2015
42.34 %
42.83 %
28.23 %
Jan 1, 2016
17.57 %
14.75 %
31.35 %
Jan 1, 2017
22.96 %
20.57 %
12.56 %
Jan 1, 2018
16.8 %
12.74 %
7.23 %
Jan 1, 2019
1.2 %
0.03 %
2.46 %
Jan 1, 2020
-30.18 %
-34.42 %
-11.56 %
Jan 1, 2021
79.49 %
25.09 %
-373.61 %
Jan 1, 2022
80.3 %
25.55 %
-18.91 %
Jan 1, 2023
83.22 %
1.28 %
-1.34 %
Jan 1, 2024
84.86 %
-57.76 %
-67 %
Invalid Date
84.86 %
-33.1 %
-35.33 %

Medicalgorithmics Stock analysis

What does Medicalgorithmics do? Medicalgorithmics is one of the most popular companies on Eulerpool.com.

Frequently Asked Questions about Medicalgorithmics stock

On Eulerpool you can find the complete historical development of Gross Profit Medicalgorithmics since 2006 – with annual values, charts, and detailed analysis.

Income Statement — Medicalgorithmics

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

All Key Metrics — Medicalgorithmics